Jon Ogg

Jon Ogg is co-founder and editor for 24/7 Wall St.

Jon has worked as a news analyst for nearly 10 years and also has experience as a broker, portfolio manager and investment adviser. He has been sourced for articles in CBS MarketWatch, E*Trade, TradeTheNews, FlyOnTheWall, Pristine, Evolution Trading, Knova Trading, Hammerstone, CNet.com, Seeking Alpha, Google Finance and other sites.

Prior to 24/7 Wall St., he formed News Contrast and was the founder of a service for active traders called TradeTheNews (which he sold in 2003) and built up a news desk that was merged into E*Trade. He also worked in Copenhagen, Denmark as a portfolio manager for European clients trading U.S. equities and ran the event-driven trading team there.

He has been a financial adviser and has advised start-up and emerging-stage companies, and started his career as a licensed broker selling fixed income to some of the largest investment managers in the United States. He received a B.B.A. in Finance from the University of Houston (1992).

Jon does not hold any positions in any stocks he writes about.

Recent Articles

2 Ways to Profit From RIMM’s Struggles

By Jon Ogg

BlackBerry-maker Research In Motion Limited (NASDAQ: RIMM) is losing market share to iPhones and Droids. Here are two ways to play the stock's slide.

China Yuan Investing – Chinese ETFs CYB and FXI

By Jon Ogg

China is revaluing its currency, the yuan, in a way. China pledged over the weekend to allow greater flexibility in exchange rates for the currency. Forex investors cheered this This is the second move to de-peg the yuan or renminbi against the U.S. Dollar but it is not a free-float of their exchange rates. The good news is that there is an ETF for this via the WisdomTree Dreyfus Chinese Yuan (NYSE: CYB).

High Dividend Yield Stocks – Where’s the Biotech Payday? (AMGN, GENZ, BBH, PFE, MRK)

By Jon Ogg

Amgen Inc. (NASDAQ: AMGN) and Genzyme Corporation (NASDAQ: GENZ) are two dead money biotech giants which are trying to turn their ships around. The reason for each being dead as a stock is a night and day difference. But both have a quest to boost long-term value, and so far both have resisted the call to begin making high yield dividend payments.

BP Calls Could Deliver Some Slick Profits

By Jon Ogg

BP plc (NYSE: BP) will be in trouble for quite some time, but with the stock near its 52-week low, these longer-term call options could pay off.

Sallie Mae Looks Like a Smart Trade

By Jon Ogg

Buying call options on student loan company SLM Corporation (NYSE: SLM) could have you feeling pretty smart this summer.

BP Has Hidden Concern: Rising Default Swap Rates (BP, RIG, HAL)

By Jon Ogg

BP plc (BP) has been nothing short of a disaster. It seems that if anything can fail or go wrong with the disaster recovery, then it goes wrong and gets even worse. But things are getting worse for the company. While it still seems impossible to fathom a credit default from the likes of a BP, the cost to insure BP debt against default is rising.

TIVO Options – Speculative TIVO Options Could Record Big Profits

By Jon Ogg

<strong>TiVo Inc.</strong> (NASDAQ: TIVO) was cut in half following news that its patent victory would be heard in appeals court. But a reversal trade could have you seeing green.

BZH Options – Get Homebuilder BZH at a Discount

By Jon Ogg

<strong>Beazer Homes USA Inc.</strong> (NYSE: BZH) is up big on an upgrade and hedge fund interest, but rather than chase the stock, you can use options to buy it at a discount.

Sirius XM Radio Up on Strange Guidance Move (SIRI)

By Jon Ogg

Sirius XM Radio Inc. (NASDAQ: SIRI) is up today following a strange guidance move in which the company raised estimates for the whole year only days after reporting a surprise profit.

Buy Put Options on Gold ETF GLD

By Jon Ogg

Gold recently hit a record high and may keep going up. But if you have some speculative cash lying around, a bet against that could make you a nice profit.

Load More